rxstatShortages › Clonazepam

Clonazepam shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Clonazepam products are in shortage in Canada (5 of 21 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
5 / 21
In shortage since
Aug 11, 2017
Reports on file
52
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
PRO-CLONAZEPAM
2MG · TABLET · PRO DOC LIMITEE
DIN 02311615 · since Jul 4, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
PRO-CLONAZEPAM
1MG · TABLET · PRO DOC LIMITEE
DIN 02311607 · since Jul 4, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CLONAZEPAM
0.5MG · TABLET · APOTEX INC
DIN 02177889 · since Jun 9, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CLONAZEPAM
2MG · TABLET · APOTEX INC
DIN 02177897 · since Mar 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-CLONAZEPAM
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02239024 · since Aug 11, 2017, no end estimate · Shortage of an active ingredient.
Active shortage
TEVA-CLONAZEPAM
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02239024 · since Aug 11, 2017, no end estimate · Shortage of an active ingredient.
Anticipated
PRO-CLONAZEPAM
0.5MG · TABLET · PRO DOC LIMITEE
DIN 02311593 · Disruption of the manufacture of the drug.
Resolved
APO-CLONAZEPAM
0.5MG · TABLET · APOTEX INC
DIN 02177889 · ended Feb 13, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-CLONAZEPAM
2MG · TABLET · APOTEX INC
DIN 02177897 · ended Feb 13, 2025 · Disruption of the manufacture of the drug.
Resolved
RIVOTRIL
0.5MG · TABLET · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 00382825 · ended Mar 31, 2023 · Disruption of the manufacture of the drug.
Resolved
RIVOTRIL
2MG · TABLET · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 00382841 · ended Mar 31, 2023 · Disruption of the manufacture of the drug.
Resolved
PMS-CLONAZEPAM- TAB 0.25MG
0.25MG · TABLET · PHARMASCIENCE INC
DIN 02179660 · ended Aug 16, 2019 · Disruption of the manufacture of the drug.

Showing 12 of 52 reports. All reports are on file with Health Canada.

What's happening

Clonazepam is currently affected by 5 active shortage reports filed with Health Canada by PRO DOC LIMITEE, APOTEX INC, TEVA CANADA LIMITED.

The reported causes are: disruption of the manufacture of the drug; shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Clonazepam is classified under “ANTIEPILEPTICS” (ATC N03AE).

Recent changes

Common questions

When will Clonazepam be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Clonazepam in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiepileptics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.